Trademark: 88644845
Status Date
Monday, March 27, 2023
Filing Date
Monday, October 7, 2019
Published for Opposition
Tuesday, June 23, 2020
Abandoned Date
Monday, March 27, 2023
5 human pharmaceutical preparations for the treatment of viral and infectious related diseases, metabolic diseases, central nervous system diseases, and cardiovascular diseases; vaccines
Mar 27, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 27, 2023
Abandonment - No Use Statement Filed
Aug 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 12, 2022
Sou Extension 4 Granted
Aug 12, 2022
Sou Extension 4 Filed
Aug 12, 2022
Teas Extension Received
Feb 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 14, 2022
Sou Extension 3 Granted
Feb 14, 2022
Sou Extension 3 Filed
Feb 14, 2022
Teas Extension Received
Aug 12, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 10, 2021
Sou Extension 2 Granted
Aug 10, 2021
Sou Extension 2 Filed
Aug 10, 2021
Teas Extension Received
Nov 25, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 23, 2020
Sou Extension 1 Granted
Nov 23, 2020
Sou Extension 1 Filed
Nov 23, 2020
Teas Extension Received
Aug 18, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 23, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 23, 2020
Published For Opposition
Jun 3, 2020
Notification Of Notice Of Publication E-Mailed
May 18, 2020
Approved For Pub - Principal Register
May 18, 2020
Teas/Email Correspondence Entered
May 18, 2020
Correspondence Received In Law Office
May 18, 2020
Teas Response To Office Action Received
Nov 25, 2019
Notification Of Non-Final Action E-Mailed
Nov 25, 2019
Non-Final Action E-Mailed
Nov 25, 2019
Non-Final Action Written
Nov 22, 2019
Assigned To Examiner
Oct 10, 2019
New Application Office Supplied Data Entered
Oct 10, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
